



About project
Project acronym RESCALE-EV Project type PRISM
Extracellular vesicles (EVs) have been identified as an important signaling mediator in a myriad of physiological and pathological processes. Due to their presence in biological fluids, EVs are emerging as a novel source for the diagnosis of diseases, prognosis and treatment monitoring, and for predicting future risk of disease development. Nevertheless, a significant leap toward the establishment of novel tools has to be made in order to utilize the full diagnostic potential of EVs.
News

Exosomal Prostate-Specific Membrane Antigen (PSMA) and Caveolin-1 as Potential Biomarkers of Prostate Cancer
Prostate-specific membrane antigen (PSMA) and caveolin-1 are membrane proteins that are overexpressed in prostate cancer (PCa) and are involved in tumor growth and…
Urinary Extracellular Vesicles as a Readily Available Biomarker Source: A Simplified Stratification Method
This study introduces an immunoaffinity-based method for isolating urinary extracellular vesicles (uEVs), offering advantages over the traditional ultracentrifugation approach in terms of purity…
Advancing REversible immunocapture toward SCALablE EV purification: NEWS & UPDATES
Welcome to this year’s newsletter of RESCALE-EV project We’re excited to share the latest updates, achievements, and upcoming events at our company. Newsletter:…